These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23411443)

  • 41. Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.
    Li H; Li Y; Wang X; Hou Y; Hong X; Gong T; Zhang Z; Sun X
    Theranostics; 2017; 7(18):4383-4398. PubMed ID: 29158834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nanoliposomal vaccine containing long multi-epitope peptide E75-AE36 pulsed PADRE-induced effective immune response in mice TUBO model of breast cancer.
    Zamani P; Teymouri M; Nikpoor AR; Navashenaq JG; Gholizadeh Z; Darban SA; Jaafari MR
    Eur J Cancer; 2020 Apr; 129():80-96. PubMed ID: 32145473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eliciting T cell immunity against poorly immunogenic tumors by immunization with dendritic cell-tumor fusion vaccines.
    Wang J; Saffold S; Cao X; Krauss J; Chen W
    J Immunol; 1998 Nov; 161(10):5516-24. PubMed ID: 9820528
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Engulfing tumors with synthetic extracellular matrices for cancer immunotherapy.
    Hori Y; Stern PJ; Hynes RO; Irvine DJ
    Biomaterials; 2009 Dec; 30(35):6757-67. PubMed ID: 19766305
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous CD8+ T cell responses to multiple tumor antigen epitopes in a multipeptide melanoma vaccine.
    Valmori D; Dutoit V; Ayyoub M; Rimoldi D; Guillaume P; Liénard D; Lejeune F; Cerottini JC; Romero P; Speiser DE
    Cancer Immun; 2003 Oct; 3():15. PubMed ID: 14580186
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Update on immunotherapy for melanoma.
    Ribas A
    J Natl Compr Canc Netw; 2006 Aug; 4(7):687-94. PubMed ID: 16884670
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effective cancer immunotherapy by natural mouse conventional type-1 dendritic cells bearing dead tumor antigen.
    Wculek SK; Amores-Iniesta J; Conde-Garrosa R; Khouili SC; Melero I; Sancho D
    J Immunother Cancer; 2019 Apr; 7(1):100. PubMed ID: 30961656
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Augmenting major histocompatibility complex class I expression by murine tumors in vivo enhances antitumor immunity induced by an active immunotherapy strategy.
    Merritt RE; Yamada RE; Crystal RG; Korst RJ
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):355-64. PubMed ID: 14762342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Solid-in-Oil Peptide Nanocarriers for Transcutaneous Cancer Vaccine Delivery against Melanoma.
    Wakabayashi R; Sakuragi M; Kozaka S; Tahara Y; Kamiya N; Goto M
    Mol Pharm; 2018 Mar; 15(3):955-961. PubMed ID: 29397746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The STEAP1(262-270) peptide encapsulated into PLGA microspheres elicits strong cytotoxic T cell immunity in HLA-A*0201 transgenic mice--A new approach to immunotherapy against prostate carcinoma.
    Herrmann VL; Wieland DE; Legler DF; Wittmann V; Groettrup M
    Prostate; 2016 Apr; 76(5):456-68. PubMed ID: 26715028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effective strategy of dendritic cell-based immunotherapy for advanced tumor-bearing hosts: the critical role of Th1-dominant immunity.
    Mashino K; Sadanaga N; Tanaka F; Ohta M; Yamaguchi H; Mori M
    Mol Cancer Ther; 2002 Aug; 1(10):785-94. PubMed ID: 12492111
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells.
    Zhang L; Tang Y; Akbulut H; Zelterman D; Linton PJ; Deisseroth AB
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15101-6. PubMed ID: 14645711
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistologic responses within dermal metastatic melanoma lesions of patients treated with a synthetic peptide vaccine.
    Fritsch M; Rosenberg SA; Duray PH
    J Immunother; 2000; 23(5):557-69. PubMed ID: 11001549
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer immunotherapy in clinical oncology.
    Knuth A; Jäger D; Jäger E
    Cancer Chemother Pharmacol; 2000; 46 Suppl():S46-51. PubMed ID: 10950148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Active antiviral T-lymphocyte response can be redirected against tumor cells by antitumor antibody x MHC/viral peptide conjugates.
    Cesson V; Stirnemann K; Robert B; Luescher I; Filleron T; Corradin G; Mach JP; Donda A
    Clin Cancer Res; 2006 Dec; 12(24):7422-30. PubMed ID: 17189415
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic vaccination against the melanocyte lineage-specific antigen gp100 induces cytotoxic T lymphocyte-mediated tumor protection.
    Schreurs MW; de Boer AJ; Figdor CG; Adema GJ
    Cancer Res; 1998 Jun; 58(12):2509-14. PubMed ID: 9635569
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.
    Umlauf BJ; Chung CY; Brown KC
    Mol Ther; 2015 Jun; 23(6):1092-1102. PubMed ID: 25868400
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cancer immunotherapy using a DNA vaccine encoding a single-chain trimer of MHC class I linked to an HPV-16 E6 immunodominant CTL epitope.
    Huang CH; Peng S; He L; Tsai YC; Boyd DA; Hansen TH; Wu TC; Hung CF
    Gene Ther; 2005 Aug; 12(15):1180-6. PubMed ID: 15800656
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythrocyte Membrane-Enveloped Polymeric Nanoparticles as Nanovaccine for Induction of Antitumor Immunity against Melanoma.
    Guo Y; Wang D; Song Q; Wu T; Zhuang X; Bao Y; Kong M; Qi Y; Tan S; Zhang Z
    ACS Nano; 2015 Jul; 9(7):6918-33. PubMed ID: 26153897
    [TBL] [Abstract][Full Text] [Related]  

  • 60. STING activator c-di-GMP enhances the anti-tumor effects of peptide vaccines in melanoma-bearing mice.
    Wang Z; Celis E
    Cancer Immunol Immunother; 2015 Aug; 64(8):1057-66. PubMed ID: 25986168
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.